# RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine

> **NCT05513560** · PHASE2,PHASE3 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 460 (actual)

## Conditions studied

- Long COVID
- Post COVID Condition
- Post Acute Sequelae of COVID-19

## Interventions

- **DRUG:** Ibudilast
- **DRUG:** Pentoxifylline
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05513560
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-31
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 460 (ACTUAL)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05513560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05513560, "RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05513560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*